PMID- 19321972 OWN - NLM STAT- MEDLINE DCOM- 20090921 LR - 20151119 IS - 1423-0348 (Electronic) IS - 0033-3190 (Linking) VI - 78 IP - 3 DP - 2009 TI - Changes in CREB phosphorylation and BDNF plasma levels during psychotherapy of depression. PG - 187-92 LID - 10.1159/000209350 [doi] AB - BACKGROUND: The cyclic adenosine monophosphate response element-binding proteins (CREB) and their interaction with brain-derived neurotrophic factor (BDNF) are essential elements in signal transduction pathways important for cellular resilience and neuroplasticity. They play a decisive role in the concept of altered neuroplasticity in major depression. We have previously demonstrated that the increase in phosphorylated CREB (pCREB) in T lymphocytes is significantly associated with clinical improvement in patients treated with antidepressants. In the present study, we focused on patients treated only with psychotherapy to exclude direct pharmacological actions. In addition to pCREB, we also measured the BDNF plasma levels. METHODS: pCREB in T lymphocytes was determined by Western blot; the BDNF plasma levels with solid-phase ELISA. Psychopathology was evaluated with the Hamilton Rating Scale for Depression (HAMD). Thirty patients meeting DSM-IV criteria for major depressive episodes (MDE) were recruited into this 6-week study. They received interpersonal psychotherapy (IPT) twice weekly. RESULTS: After 6 weeks of IPT, 17 patients responded (reduction of > or =50% of baseline HAMD); after 1 week of treatment pCREB increased significantly compared to the nonresponder group. Measurement of the BDNF plasma levels revealed no differences between the responder and nonresponder groups. Furthermore, the correlations between BDNF plasma levels and pCREB were not significant. CONCLUSIONS: The early increase in pCREB is related to treatment response and does not depend on pharmacological interventions or BDNF plasma levels. For the first time, cellular biological markers could be associated with response to psychotherapy. CI - Copyright (c) 2009 S. Karger AG, Basel. FAU - Koch, Jakob M AU - Koch JM AD - Department of Psychiatry and Psychotherapy, Christian-Albrechts University Kiel, Niemannsweg 147, Kiel, Germany. j.koch@zip-kiel.de FAU - Hinze-Selch, Dunja AU - Hinze-Selch D FAU - Stingele, Karoline AU - Stingele K FAU - Huchzermeier, Christian AU - Huchzermeier C FAU - Goder, Robert AU - Goder R FAU - Seeck-Hirschner, Mareen AU - Seeck-Hirschner M FAU - Aldenhoff, Josef B AU - Aldenhoff JB LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20090324 PL - Switzerland TA - Psychother Psychosom JT - Psychotherapy and psychosomatics JID - 0024046 RN - 0 (Brain-Derived Neurotrophic Factor) RN - EC 2.3.1.48 (CREB-Binding Protein) SB - IM MH - Blotting, Western MH - Brain-Derived Neurotrophic Factor/*blood MH - CREB-Binding Protein/*metabolism MH - Depressive Disorder, Major/diagnosis/*metabolism/*therapy MH - Diagnostic and Statistical Manual of Mental Disorders MH - Enzyme-Linked Immunosorbent Assay MH - Female MH - Humans MH - Interpersonal Relations MH - Male MH - Neuronal Plasticity MH - *Phosphorylation MH - *Psychotherapy MH - Severity of Illness Index MH - Signal Transduction MH - Surveys and Questionnaires MH - T-Lymphocytes/metabolism EDAT- 2009/03/27 09:00 MHDA- 2009/09/22 06:00 CRDT- 2009/03/27 09:00 PHST- 2009/03/27 09:00 [entrez] PHST- 2009/03/27 09:00 [pubmed] PHST- 2009/09/22 06:00 [medline] AID - 000209350 [pii] AID - 10.1159/000209350 [doi] PST - ppublish SO - Psychother Psychosom. 2009;78(3):187-92. doi: 10.1159/000209350. Epub 2009 Mar 24.